| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
MSACL US 2019 -- Laboratories can deliver the rapid quantitation of time-critical samples in a single run with the launch of an easy-to-use, direct sampling source that is designed to decrease...
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
MSACL US 2019 – Thermo Fisher Scientific announces the expansion of its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems now listed as...
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
Pioneering thinkers from across disciplines are set to convene in a literal convergence of thought leadership in engineering, technology, science, and entrepreneurship. The Cairn Symposium takes place
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and...
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
Bolt Biotherapeutics, Inc., a biotechnology company focused on unleashing the power of the immune system to achieve anti-tumor immunity, today released positive preclinical proof of concept data...
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
John Hayes, co-founder and chief technology officer of BlackRidge Technology International, Inc. (OTCQB: BRTI), a leading provider of next-generation cyber defense solutions, has been named...
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
Primmune Therapeutics today announced that it will present preclinical data on a novel series of toll-like receptor 7 (TLR7) agonists engineered for systemic activation of innate immunity at the...
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
Geom Therapeutics, Inc., a privately held biopharmaceutical company focused on the development of novel antibiotics for multidrug-resistant (MDR) gram-negative infections, today announced upcoming...
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
As laboratories increasingly look to bring advanced molecular testing in-house, the results of a new retrospective clinical research study show that tumor mutation burden (TMB) assessments...
-
Apr 1, 2019Virtual Press Office and PR Newswire: General Trade show news
GenScript®, the world's leading gene synthesis provider, today at the American Association for Cancer Research launched a single-stranded DNA (ssDNA) service. The new service offers researchers...
